Ligand To Acquire XOMA Royalty For Around $739 Mln, Both Stocks Up In Pre-market
27/4 13:54
(RTTNews) - Ligand Pharmaceuticals Incorporated (LGND) and XOMA Royalty Corporation (XOMA), both biotechnology royalty aggregators, Monday, announced that Ligand will acquire XOMA Royalty for $39 per share for a total equity value of around $739 million....